Increased expression of in situ CD123 and reduced Toll‐like receptor 7/9 signalling pathway suggest impaired activation of plasmacytoid dendritic cells in recurrent erythema multiforme

Documenti analoghi

• Flagellate erythema in anti‐ MDA5 ‐positive dermatomyositis
  di: Sheng‐Ni Chen, et al.
  Pubblicazione: (2026)
• Novel drugs for the management of recalcitrant erythema nodosum leprosum
  di: Mayra Ianhez, et al.
  Pubblicazione: (2025)
• Residual facial erythema in atopic dermatitis patients treated with dupilumab stratified by machine learning
  di: Koichi Ashizaki, et al.
  Pubblicazione: (2024)
• Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases
  di: S. Krämer, et al.
  Pubblicazione: (2024)
• Dynamic optical coherence tomography evaluation in locally advanced basal cell carcinoma during sonidegib treatment
  di: C. Cantisani, et al.
  Pubblicazione: (2024)